Results 1 to 10 of about 58,194 (262)

The Health Professional’s View on the Inclusion of Age in the Recommendations for Pneumococcal Vaccination: Results of a Cross-Sectional Survey in France [PDF]

open access: goldGeriatrics, 2021
Elderly people are at high risk for pneumococcal infections. However, older age is not an eligibility factor for pneumococcal vaccination in France. Adults with certain co-morbidities or immunocompromised states are eligible for vaccination, which leaves
Gaëlle Farge   +5 more
doaj   +2 more sources

Approaches to vaccination of adults against pneumococcal disease in different countries of the world

open access: diamondЖурнал инфектологии
Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination  against  pneumococcal infection is recommended
A. S. Korovkin   +2 more
doaj   +3 more sources

Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey [PDF]

open access: yesHuman Vaccines & Immunotherapeutics
This study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were ...
Youngju Kim   +4 more
doaj   +2 more sources

Analysis of Sequential Pneumococcal Vaccination Coverage in the Elderly Resident Population of the Viterbo Local Health Authority from 2018 to 2023 [PDF]

open access: yesVaccines
Background: Pneumococcal disease is a significant health burden, particularly among older adults and individuals with chronic conditions. Sequential pneumococcal vaccination (PCV13 followed by PPSV23) has been recommended in Italy since 2017 for its ...
Andrea Bongiovanni   +5 more
doaj   +2 more sources

Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]

open access: yes, 2014
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
A Fenoll   +91 more
core   +23 more sources

Attitudes Toward General Vaccination Mediate the Association Between Influenza Vaccination History and Pneumococcal Vaccination Intention Among Older Adults in China [PDF]

open access: yesVaccines
Background: Influenza and pneumococcal vaccinations play a crucial role in disease prevention among older adults and are recommended to older adults aged 60 years and over in China, but the vaccination rates are suboptimal. Behavioral spillover indicates
Siwen Huang   +15 more
doaj   +2 more sources

A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China

open access: yesFrontiers in Public Health, 2022
IntroductionVaccination is the most effective measure for prevention against infectious diseases in patients with systemic lupus erythematosus (SLE). Therefore, it is important to know SLE patients' attitudes toward influenza and pneumococcal vaccination.
Yanling Chen   +6 more
doaj   +1 more source

Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis

open access: yesFrontiers in Medicine, 2023
IntroductionPatients with rheumatoid arthritis (RA) are at increased risk for serious infections. Pneumococcal vaccination is among the most important preventive measures, however, vaccine uptake is suboptimal. We explored the rate and factors associated
Konstantinos Thomas   +33 more
doaj   +1 more source

Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions

open access: yesHuman Vaccines & Immunotherapeutics, 2023
The Centers for Disease Control recommends pneumococcal vaccination for U.S. adults aged 19–64 years with chronic or immunocompromising conditions, however, vaccination coverage is low and regional variations in coverage are rarely studied.
Junqing Liu   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy